Sandbox 250: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
Mentors: Joel Sussman, Weissman Institule of Science, and Lars Westblade, Touro College of Pharmacy. | Mentors: Joel Sussman, Weissman Institule of Science, and Lars Westblade, Touro College of Pharmacy. | ||
---- | |||
<applet load='2ace' size='300' frame='true' align='left' scene='Sandbox_250/Ache_ach/30' caption='AChE in complex with ACh'/> | <applet load='2ace' size='300' frame='true' align='left' scene='Sandbox_250/Ache_ach/30' caption='AChE in complex with ACh'/> | ||
| Line 99: | Line 99: | ||
---- | |||
==='''Introduction'''=== | ==='''Introduction'''=== | ||
| Line 107: | Line 107: | ||
---- | |||
==='''Designing Physical Models to Tell the Story of Acetylcholinesterase'''=== | ==='''Designing Physical Models to Tell the Story of Acetylcholinesterase'''=== | ||
| Line 157: | Line 157: | ||
---- | |||
==='''References'''=== | ==='''References'''=== | ||
| Line 169: | Line 172: | ||
5. Greenblatt, Harry M., Dvir, Hay,Silman, Isreal, Sussman, Joel L. (2002). Acetylcholinesterase: A Multidaceted Target for Strucutre-Based Drug Design of Anitcholinesterase Agents for the Treatment of Alzheimer’s Disease in Journal of Molecular Neuroscience 20, 369-383. | 5. Greenblatt, Harry M., Dvir, Hay,Silman, Isreal, Sussman, Joel L. (2002). Acetylcholinesterase: A Multidaceted Target for Strucutre-Based Drug Design of Anitcholinesterase Agents for the Treatment of Alzheimer’s Disease in Journal of Molecular Neuroscience 20, 369-383. | ||
---- | |||
==='''Acknowledgements'''=== | ==='''Acknowledgements'''=== | ||